Standout Papers

Screening for depression in well older adults: evaluation of a short form of the CES-D (Cente... 1994 2026 2004 2015 3.9k
  1. Screening for depression in well older adults: evaluation of a short form of the CES-D (Center for Epidemiologic Studies Depression Scale). (1994)
    Elena M. Andresen, Judith A. Malmgren et al. PubMed
  2. The COSMIN study reached international consensus on taxonomy, terminology, and definitions of measurement properties for health-related patient-reported outcomes (2010)
    Lidwine B. Mokkink, Caroline B. Terwee et al. Journal of Clinical Epidemiology
  3. The COSMIN checklist for assessing the methodological quality of studies on measurement properties of health status measurement instruments: an international Delphi study (2010)
    Lidwine B. Mokkink, Caroline B. Terwee et al. Quality of Life Research
  4. COSMIN guideline for systematic reviews of patient-reported outcome measures (2018)
    C.A.C. Prinsen, Lidwine B. Mokkink et al. Quality of Life Research
  5. The validity of self-reported smoking: a review and meta-analysis. (1994)
    Donald L. Patrick, Allen Cheadle et al. American Journal of Public Health
  6. COSMIN Risk of Bias checklist for systematic reviews of Patient-Reported Outcome Measures (2017)
    Lidwine B. Mokkink, Henrica C. W. de Vet et al. Quality of Life Research
  7. Generic and Disease-Specific Measures in Assessing Health Status and Quality of Life (1989)
    Donald L. Patrick, Richard A. Deyo Medical Care
  8. The COSMIN checklist for evaluating the methodological quality of studies on measurement properties: A clarification of its content (2010)
    Lidwine B. Mokkink, Caroline B. Terwee et al. BMC Medical Research Methodology
  9. COSMIN methodology for evaluating the content validity of patient-reported outcome measures: a Delphi study (2018)
    Caroline B. Terwee, Alessandro Chiarotto et al. Quality of Life Research
  10. Reproducibility and responsiveness of health status measures statistics and strategies for evaluation (1991)
    Richard A. Deyo, Paula Diehr et al. Controlled Clinical Trials
  11. Content Validity—Establishing and Reporting the Evidence in Newly Developed Patient-Reported Outcomes (PRO) Instruments for Medical Product Evaluation: ISPOR PRO Good Research Practices Task Force Report: Part 2—Assessing Respondent Understanding (2011)
    Donald L. Patrick, Laurie B. Burke et al. Value in Health
  12. Content Validity—Establishing and Reporting the Evidence in Newly Developed Patient-Reported Outcomes (PRO) Instruments for Medical Product Evaluation: ISPOR PRO Good Research Practices Task Force Report: Part 1—Eliciting Concepts for a New PRO Instrument (2011)
    Donald L. Patrick, Laurie B. Burke et al. Value in Health
  13. Assessing Health-Related Quality of Life in Patients With Sciatica (1995)
    Donald L. Patrick, Richard A. Deyo et al. Spine
  14. Patient-Reported Outcomes to Support Medical Product Labeling Claims: FDA Perspective (2007)
    Donald L. Patrick, Laurie B. Burke et al. Value in Health
  15. The Rapid Assessment of Physical Activity (RAPA) among older adults. (2006)
    Tari D. Topolski, James P. LoGerfo et al. PubMed
  16. GRADE guidelines: 13. Preparing Summary of Findings tables and evidence profiles—continuous outcomes (2012)
    Gordon Guyatt, Kristian Thorlund et al. Journal of Clinical Epidemiology
  17. Pediatric Patient-Reported Outcome Instruments for Research to Support Medical Product Labeling: Report of the ISPOR PRO Good Research Practices for the Assessment of Children and Adolescents Task Force (2013)
    Louis S. Matza, Donald L. Patrick et al. Value in Health
  18. Advancing Symptom Science Through Symptom Cluster Research: Expert Panel Proceedings and Recommendations (2016)
    Christine Miaskowski, Andrea M. Barsevick et al. JNCI Journal of the National Cancer Institute
  19. COSMIN Risk of Bias tool to assess the quality of studies on reliability or measurement error of outcome measurement instruments: a Delphi study (2020)
    Lidwine B. Mokkink, Maarten Boers et al. BMC Medical Research Methodology

Immediate Impact

1 from Science/Nature 62 standout
Sub-graph 1 of 22

Citing Papers

Crohn's disease
2024 Standout
Oral rimegepant for preventive treatment of migraine: a phase 2/3, randomised, double-blind, placebo-controlled trial
2020 Standout

Works of Donald L. Patrick being referenced

A New Instrument to Assess the Long‐term Quality of Life Effects From Migraine: Development and Psychometric Testing of the MSQOL
1996
The rating form of IBD patient concerns: a new measure of health status.
1991

Author Peers

Author Last Decade Papers Cites
Donald L. Patrick 9202 5417 8282 6762 422 47.2k
Jordi Alonso 10340 4727 5999 4505 453 52.0k
Caroline B. Terwee 6090 4325 5586 10584 371 46.6k
Theo Vos 7843 2842 6938 3579 297 48.4k
John E. Ware 13288 5879 5416 8073 147 54.0k
Paul Glasziou 11692 6976 10787 9945 622 64.4k
Ron D. Hays 17488 9864 7283 5595 841 65.9k
Jonathan A C Sterne 5962 4024 8898 12776 380 80.4k
David L. Streiner 7390 2449 5691 3309 537 41.8k
Víctor M. Montori 13626 6911 11803 13008 678 74.4k
Henrica C. W. de Vet 8916 5484 7091 13658 518 66.5k

All Works

Loading papers...

Rankless by CCL
2026